ADVFN Logo ADVFN

Wir konnten keine Ergebnisse für:
Stelle sicher, dass deine Schreibweise korrekt ist oder versuche deine Suche zu erweitern.

Trends

Toplisten

Es scheint, dass du nicht eingeloggt bist.
Klicke auf den Button unten, um dich einzuloggen und deine zuletzt angesehenen Aktien zu sehen.

Hot Features

Registration Strip Icon for monitor Überwachen Sie mehrere Echtzeitkurse von führenden Börsen wie NASDAQ, NYSE, AMEX, Bovespa und mehr.

MCRB Seres Therapeutics Inc

1,16
0,05 (4,50%)
Nach Börsenschluss
Zuletzt aktualisiert: 01:02:24
Verzögert um 15 Minuten
Name Symbol Markt Aktientyp
Seres Therapeutics Inc MCRB NASDAQ Common Stock
  Änderung Änderung % Aktuell Zeit
0,05 4,50% 1,16 01:02:24
Handelsbeginn Niedrig Hoch Schlusskurs Handelsende
1,11 1,08 1,19 1,16 1,11
more quote information »

Aktuelle News

Datum Zeit Quelle Überschrift
09.4.202413:00BWSeres Therapeutics Announces Completion of Patient..
28.3.202412:00BWSeres Therapeutics Reports Inducement Grants Under Nasdaq..
19.3.202412:00BWSeres Therapeutics Reports Inducement Grants Under Nasdaq..
05.3.202416:18EDGAR2Form DEF 14A - Other definitive proxy statements
05.3.202416:13EDGAR2Form S-8 - Securities to be offered to employees in employee..
05.3.202413:05EDGAR2Form 8-K - Current report
05.3.202413:00BWSeres Therapeutics Reports Fourth Quarter and Full Year 2023..
05.3.202412:05IHMARKETNEWSU.S. Futures Dip, Crude Oil Fluctuates
28.2.202413:00BWSeres Therapeutics to Host Fourth Quarter 2023 Financial..
27.2.202413:00BWSeres Therapeutics to Participate in Cowen 44th Annual..
26.2.202413:06EDGAR2Form 8-K - Current report
26.2.202413:00BWSeres Therapeutics Announces the Appointment of Marella..
23.2.202422:05EDGAR2Form PRE 14A - Other preliminary proxy statements
17.2.202403:42EDGAR2Form 4 - Statement of changes in beneficial ownership of..
17.2.202403:31EDGAR2Form 4 - Statement of changes in beneficial ownership of..
17.2.202403:29EDGAR2Form 4 - Statement of changes in beneficial ownership of..
17.2.202403:21EDGAR2Form 4 - Statement of changes in beneficial ownership of..
17.2.202403:15EDGAR2Form 4 - Statement of changes in beneficial ownership of..
30.1.202422:01EDGAR2Form 8-K - Current report
17.1.202413:00BWSeres Therapeutics Reports Inducement Grants Under Nasdaq..
10.1.202413:00EDGAR2Form 8-K - Current report
09.1.202414:10DJNSeres Therapeutics Shares Rise 15% After Getting FDA..
09.1.202413:05EDGAR2Form 8-K - Current report
09.1.202413:00BWSeres Therapeutics Announces VOWST™ Commercial Launch Update..
04.1.202422:00BWSeres Therapeutics to Participate in the 42nd Annual J.P...
02.1.202422:05EDGAR2Form 8-K - Current report
08.12.202301:46BWSeres Therapeutics Announces Presentation of Preliminary..
28.11.202315:18BWSeres Therapeutics to Participate in the Piper Sandler 35th..
28.11.202301:01PRNUSFlagship Pioneering Marks Official Opening of UK Hub with..
21.11.202312:00PRNUSFlagship Pioneering Unveils Quotient Therapeutics to Create..
02.11.202315:00EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
02.11.202312:05EDGAR2Form 8-K - Current report
02.11.202312:00BWSeres Therapeutics Reports Third Quarter 2023 Financial..
01.11.202315:30PRNUSFlagship Pioneering Launches Pioneering Intelligence
01.11.202302:43EDGAR2Form 4 - Statement of changes in beneficial ownership of..
01.11.202302:40EDGAR2Form 4 - Statement of changes in beneficial ownership of..
01.11.202302:40EDGAR2Form 4 - Statement of changes in beneficial ownership of..
01.11.202302:39EDGAR2Form 4 - Statement of changes in beneficial ownership of..
01.11.202302:36EDGAR2Form 4 - Statement of changes in beneficial ownership of..
01.11.202302:36EDGAR2Form 4 - Statement of changes in beneficial ownership of..
30.10.202322:30BWSeres Therapeutics to Announce Third Quarter 2023 Results on..
12.10.202313:00BW Seres Therapeutics to Highlight VOWST™ Data at IDWeek
06.10.202313:00BWSeres Therapeutics Reports Inducement Grants Under Nasdaq..
04.10.202313:00EDGAR2Form 8-K - Current report
11.9.202312:30PRNUSFlagship Pioneering Announces Appointment of Amanda Kay as..
08.9.202313:00BWSeres Therapeutics Reports Inducement Grants Under Nasdaq..
07.9.202316:00BWSeres Therapeutics to Participate in the Morgan Stanley 21st..
29.8.202315:00PRNUSInvaio achieves first registration for citrus greening..
16.8.202306:15EDGAR2Form EFFECT - Notice of Effectiveness
08.8.202322:07EDGAR2Form S-3 - Registration statement under Securities Act of..

Kürzlich von Ihnen besucht

Delayed Upgrade Clock